Annexon (ANNX) Preferred Shares Issued (2020)

Annexon (ANNX) recorded quarterly Preferred Shares Issued of $15000.0 in Q3 2020, down 99.98% quarter-over-quarter from $96.8 million in Q2 2020.

Annexon (ANNX) Preferred Shares Issued (2020) Analysis & Trends

Annexon's Preferred Shares Issued history runs 1 years deep, the most recent figure standing at $15000.0 for Q3 2020.

In Q3 2020, Preferred Shares Issued changed N/A year-over-year to $15000.0; the TTM figure through Dec 2020 stood at $96.8 million (changed N/A YoY), while the FY2020 annual figure was $102.0 million, up 240.03% from the prior year.
Preferred Shares Issued was $15000.0 for Q3 2020 at Annexon, down from $96.8 million in the prior quarter.
In the past five years, Preferred Shares Issued ranged from a high of $96.8 million in Q2 2020 to a low of $15000.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	-
9	Abivax	95.45 Bn	95.45 Bn	-	-
10	Annexon	35.73 Mn	-189.30 Mn	-	-

Download Data